Metabolic Rates of ATP Transfer Through Creatine Kinase (CK Flux) Predict Clinical Heart Failure Events and Death

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Science Translational Medicine

• Publication date

  2013-12-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1126/scitranslmed.3007328PMID 24337482PMCID PMC4440545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Living Without Creatine: Unchanged Exercise Capacity and Response to Chronic Myocardial Infarction in Creatine-Deficient Mice

  2013cited by this paper
• Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved.

  2012influential reference
• Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts.

  2012influential reference
• Eplerenone in patients with systolic heart failure and mild symptoms.

  2011cited by this paper
• Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Triple repetition time saturation transfer (TRiST) 31P spectroscopy for measuring human creatine kinase reaction kinetics

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction

  2009cited by this paper
• Cardiovascular outcomes in randomized trials: should time to first event for "hard" end points remain the standard approach?

  2009cited by this paper
• Magnetic resonance spectroscopy in myocardial disease.

  2009cited by this paper
• Reduced Myocardial Creatine Kinase Flux in Human Myocardial Infarction: An In Vivo Phosphorus Magnetic Resonance Spectroscopy Study

  2009influential reference
• Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial.

  2009cited by this paper
• Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

  2008cited by this paper
• Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

  2008cited by this paper
• Applied Survival Analysis: Regression Modeling of Time-to-Event Data

  2008cited by this paper
• Correcting reaction rates measured by saturation-transfer magnetic resonance spectroscopy.

  2008cited by this paper
• The failing heart--an engine out of fuel.

  2007cited by this paper
• Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium

  2006influential reference
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• ATP flux through creatine kinase in the normal, stressed, and failing human heart.

  2005influential reference
• Phosphotransfer networks and cellular energetics

  2003cited by this paper
• Coupling of Cell Energetics with Membrane Metabolic Sensing

  2002cited by this paper
• Four‐angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo

  2002cited by this paper
• Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.

  2002cited by this paper
• Chronic Phosphocreatine Depletion by the Creatine Analogue &bgr;-Guanidinopropionate Is Associated With Increased Mortality and Loss of ATP in Rats After Myocardial Infarction

  2001cited by this paper
• High-Energy Phosphate Metabolism and Creatine Kinase in Failing Hearts: A New Porcine Model

  2001cited by this paper
• Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy.

  2001cited by this paper
• Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy

  2001cited by this paper
• THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE

  2000cited by this paper
• Survival analysis for recurrent event data: an application to childhood infectious diseases.

  2000cited by this paper
• Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase.

  1998cited by this paper
• Is the failing heart energy depleted?

  1998cited by this paper
• Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology

  1998cited by this paper
• Human myocardial ATP content and in vivo contractile function

  1998cited by this paper
• Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

  1997cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Cox regression analysis of multivariate failure time data: the marginal approach.

  1994cited by this paper
• Is cardiac failure a consequence of decreased energy reserve

  1993cited by this paper
• Effects of vesnarinone on morbidity and mortality in patients with heart failure

  1993cited by this paper
• Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.

  1993cited by this paper
• 31P Magnetic Resonance Spectroscopy in Dilated Cardiomyopathy and Coronary Artery Disease: Altered Cardiac High‐Energy Phosphate Metabolism in Heart Failure

  1992cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.

  1991cited by this paper
• Correcting human heart 31P NMR spectra for partial saturation. Evidence that saturation factors for PCr/ATP are homogeneous in normal and disease states

  1991cited by this paper
• Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.

  1991cited by this paper
• Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

  1991cited by this paper
• Regression analysis of multivariate incomplete failure time data by modeling marginal distributions

  1989cited by this paper
• Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy.

  1985cited by this paper
• The creatine kinase system in normal and diseased human myocardium.

  1985cited by this paper
• Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles.

  1982cited by this paper

• A clinical future for the myocardial PCr/ATP ratio?

  2026cites this paper
• The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC

  2025cites this paper
• Regionally resolved cardiac metabolism using a dipole‐loop array coil for 7 T 31P‐MRSI

  2025cites this paper
• The regulatory role of exercise in heart failure and myocardial energy metabolism: A review

  2025cites this paper
• Mitochondrial Dysfunction in Cardiovascular Diseases

  2025cites this paper
• Prognostic Circulatory Signature Metabolites of Stable Verses Unstable Angina: An Application of NMR Spectroscopy.

  2025cites this paper
• FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice

  2025cites this paper
• Myocardial energy metabolism in heart failure: Systematic review and meta-analysis of Phosphorus-31 magnetic resonance spectroscopy phosphocreatine/adenosine triphosphate ratio

  2025cites this paper
• Human induced pluripotent stem cell-derived cardiomyocytes for disease modeling and drug discovery

  2025cites this paper
• Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets

  2025cites this paper
• Analysis and validation of characteristic genes in RNA sequencing datasets from heart failure patients based on multiple algorithms

  2025cites this paper
• Imaging of metabolic dysfunction in genetic cardiomyopathies

  2025cites this paper
• Molecular Insights into the Potential Cardiometabolic Effects of GLP-1 Receptor Analogs and DPP-4 Inhibitors

  2025cites this paper
• Development of a Quantitative Systems Pharmacology Model to Interrogate Mitochondrial Metabolism in Heart Failure

  2025cites this paper
• Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets

  2025cites this paper
• Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction

  2024cites this paper
• Molecular Pathways in Diabetic Cardiomyopathy and the Role of Anti-hyperglycemic Drugs Beyond Their Glucose Lowering Effect

  2024cites this paper
• Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond

  2024cites this paper
• Leveraging metabolism for better outcomes in heart failure

  2024cites this paper
• From Gym to Medicine: Creatine Uses Beyond Athletic Performance

  2024cites this paper
• Human cardiac metabolism.

  2024cites this paper
• A Mitochondrial Basis for Heart Failure Progression

  2024cites this paper
• Maintaining energy provision in the heart: the creatine kinase system in ischaemia–reperfusion injury and chronic heart failure

  2024cites this paper
• Striated preferentially expressed gene deficiency leads to mitochondrial dysfunction in developing cardiomyocytes

  2023cites this paper
• Integrated Functions of Cardiac Energetics, Mechanics, and Purine Nucleotide Metabolism.

  2023cites this paper
• Energetic Basis of Recovered Ejection Fraction in Human Heart Failure.

  2023cites this paper
• Beneficial Effects of Halogenated Anesthetics in Cardiomyocytes: The Role of Mitochondria

  2023cites this paper
• URAT1 is expressed in cardiomyocytes and dotinurad attenuates the development of diet-induced metabolic heart disease

  2023cites this paper
• Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy

  2023cites this paper
• Energy metabolism: A critical target of cardiovascular injury.

  2023cites this paper
• Fast in vivo assay of creatine kinase activity in the human brain by 31P magnetic resonance fingerprinting

  2023cites this paper
• Gut-derived short-chain fatty acids bridge cardiac and systemic metabolism and immunity in heart failure.

  2023cites this paper
• Serum Dynamin-Related Protein 1 Concentrations Discriminate Phenotypes and Predict Prognosis of Heart Failure

  2023cites this paper
• Myocardial Metabolism in Heart Failure

  2023cites this paper
• Phosphorus Magnetic Resonance Spectroscopy (31P MRS) and Cardiovascular Disease: The Importance of Energy

  2023cites this paper
• A facile switch-on fluorescence sensing method for detecting phosphates from complex aqueous samples

  2023cites this paper
• DYRK1B-STAT3 Drives Cardiac Hypertrophy and Heart Failure by Impairing Mitochondrial Bioenergetics

  2022cites this paper
• Cardiac ^31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?

  2022cites this paper
• Metabolic substrates, histone modifications, and heart failure.

  2022cites this paper
• Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure

  2022cites this paper
• Long‐Term Activation of Glucagon‐like peptide‐1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes

  2022cites this paper
• Magnetic resonance imaging of cardiac metabolism in heart failure: how far have we come?

  2022cites this paper
• Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure

  2022cites this paper
• Myocardial ATP depletion detected noninvasively predicts sudden cardiac death risk in patients with heart failure

  2022cites this paper
• Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?

  2022cites this paper
• VDAC2 as a novel target for heart failure: Ca2+ at the sarcomere, mitochondria and SR.

  2022cites this paper
• Measuring Myocardial Energetics with Cardiovascular Magnetic Resonance Spectroscopy.

  2021cites this paper
• Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study

  2021cites this paper
• Myocardial inflammation and energetics by cardiac MRI: a review of emerging techniques

  2021cites this paper
• Cardiac Energy Metabolism in Heart Failure

  2021cites this paper
• With a grain of salt: Sodium elevation and metabolic remodelling in heart failure

  2021cites this paper
• Obesity modifies the energetic phenotype of dilated cardiomyopathy

  2021cites this paper
• Obesity modifies the energetic phenotype of dilated cardiomyopathy

  2021cites this paper
• When does too much energy become a danger to the heart?

  2021cites this paper
• PCr/ATP ratios and mitochondrial function in the heart. A comparative study in humans

  2021cites this paper
• Creatine deficiency and heart failure

  2021cites this paper
• Acetylation of muscle creatine kinase negatively impacts high-energy phosphotransfer in heart failure

  2021cites this paper
• Response by Peterzan et al to Letter Regarding Article, "Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction".

  2020cites this paper
• Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure

  2020cites this paper
• Myocardial Energetics in Obesity

  2020cites this paper
• Use of cardiac magnetic resonance to detect changes in metabolism in heart failure.

  2020cites this paper
• Cardiac Metabolic Changes in Altered Thyroid States

  2020cites this paper
• Thyroid Hormone, Mitochondrial Function and Cardioprotection

  2020cites this paper
• Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction

  2020cites this paper
• Non-invasive investigation of myocardial energetics in cardiac disease using 31P magnetic resonance spectroscopy.

  2020cites this paper
• Should CMR be the default imaging modality in clinical trials for heart failure?

  2020cites this paper
• Impaired Myocardial Energetics Causes Mechanical Dysfunction in Decompensated Failing Hearts

  2020cites this paper
• Xanthine oxidase inhibition attenuates doxorubicin-induced cardiotoxicity in mice.

  2020cites this paper
• Cardiac Energetics Before, During, and After Anthracycline-Based Chemotherapy in Breast Cancer Patients Using 31P Magnetic Resonance Spectroscopy: A Pilot Study

  2020cites this paper
• Role of Mitochondria in Cardiovascular Comorbidities Associated with Obesity and Type 2 Diabetes

  2019cites this paper
• Metabolomics in early detection and prognosis of acute coronary syndrome.

  2019cites this paper
• Investigation of the metabolic difference between ST-elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS

  2019cites this paper
• CMR to Assess Morphology, Function, Perfusion, and Viability

  2019cites this paper
• CEST MRI reveals a correlation between visceral fat mass and reduced myocardial creatine in obese individuals despite preserved ventricular structure and function

  2019cites this paper
• Energy Metabolism in the Failing Right Ventricle: Limitations of Oxygen Delivery and the Creatine Kinase System

  2019cites this paper
• The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense.

  2019cites this paper
• High Serum Uric Acid is Highly Associated with a Reduced Left Ventricular Ejection Fraction Rather than Increased Plasma B-type Natriuretic Peptide in Patients with Cardiovascular Diseases

  2019cites this paper
• The current state of biomarker research for Friedreich’s ataxia: a report from the 2018 FARA biomarker meeting

  2019cites this paper
• Neural-network classification of cardiac disease from 31P cardiovascular magnetic resonance spectroscopy measures of creatine kinase energy metabolism

  2019influential citation
• Fine particles cause the abnormality of cardiac ATP levels via PPARɑ-mediated utilization of fatty acid and glucose using in vivo and in vitro models.

  2019cites this paper
• Multiplexed Optical Imaging of Energy Substrates Reveals That Left Ventricular Hypertrophy Is Associated With Brown Adipose Tissue Activation

  2018cites this paper
• Cardiac work is related to creatine kinase energy supply in human heart failure: a cardiovascular magnetic resonance spectroscopy study

  2018cites this paper
• Metabolic remodelling in heart failure

  2018cites this paper
• [5. Evaluation of Pathology of Heart Disease Models Using Preclinical Ultra-high Field MRI].

  2018cites this paper
• Energetic metabolism in cardiomyocytes: molecular basis of heart ischemia and arrhythmogenesis

  2017cites this paper
• Metabolic remodeling in hypertrophied and failing myocardium: a review.

  2017cites this paper
• Metabolomics-driven understanding of genotype-phenotype relations in model organisms

  2017cites this paper
• Evaluation of cardiac energetics by non-invasive 31P magnetic resonance spectroscopy.

  2017cites this paper
• Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure

  2017cites this paper
• Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis

  2017cites this paper
• The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure.

  2016cites this paper
• Metabolism: Beyond the power of mitochondria

  2016cites this paper
• Measuring Biochemical Reaction Rates In Vivo with Magnetization Transfer

  2016cites this paper
• Nitric Oxide Synthase Uncoupling in Tumor Progression and Cancer Therapy

  2016cites this paper
• Energetics in the Hypertrophied and Failing Heart

  2016cites this paper
• MRS studies of muscle and heart in obesity and diabetes

  2016cites this paper
• MRS in the failing heart: From mice to humans

  2016cites this paper
• Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation

  2016cites this paper
• MRS studies of creatine kinase metabolism in human heart

  2016cites this paper
• Identification of nondiabetic heart failure-associated genes by bioinformatics approaches in patients with dilated ischemic cardiomyopathy.

  2016cites this paper